Molecular Mechanisms Involved in Hypoxia-Induced Alterations in Bone Remodeling.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
    • Publication Information:
      Original Publication: Basel, Switzerland : MDPI, [2000-
    • Subject Terms:
    • Abstract:
      Bone is crucial for the support of muscles and the protection of vital organs, and as a reservoir of calcium and phosphorus. Bone is one of the most metabolically active tissues and is continuously renewed to adapt to the changes required for healthy functioning. To maintain normal cellular and physiological bone functions sufficient oxygen is required, as evidence has shown that hypoxia may influence bone health. In this scenario, this review aimed to analyze the molecular mechanisms involved in hypoxia-induced bone remodeling alterations and their possible clinical consequences. Hypoxia has been associated with reduced bone formation and reduced osteoblast matrix mineralization due to the hypoxia environment inhibiting osteoblast differentiation. A hypoxic environment is involved with increased osteoclastogenesis and increased bone resorptive capacity of the osteoclasts. Clinical studies, although with contradictory results, have shown that hypoxia can modify bone remodeling.
    • References:
      PLoS One. 2014 Nov 06;9(11):e111845. (PMID: 25375896)
      Cell. 2001 Oct 5;107(1):43-54. (PMID: 11595184)
      Stem Cell Rev Rep. 2014 Feb;10(1):69-78. (PMID: 24052411)
      J Pathol. 2017 Jul;242(3):322-333. (PMID: 28418093)
      Bone Res. 2013 Sep 25;1(3):203-15. (PMID: 26273504)
      J Cell Biochem. 2010 May 15;110(2):457-67. (PMID: 20336693)
      Clin J Am Soc Nephrol. 2008 Nov;3 Suppl 3:S131-9. (PMID: 18988698)
      Exp Cell Res. 2006 Jun 10;312(10):1693-702. (PMID: 16529738)
      Physiology (Bethesda). 2016 May;31(3):233-45. (PMID: 27053737)
      Med Sci Monit. 2016 Aug 23;22:2962-71. (PMID: 27550548)
      Cancer Res. 2005 Apr 15;65(8):3299-306. (PMID: 15833863)
      Bone Res. 2019 Feb 21;7:7. (PMID: 30792937)
      FASEB J. 2015 May;29(5):1890-900. (PMID: 25630969)
      Blood. 2002 Jan 1;99(1):394. (PMID: 11783438)
      Sci Rep. 2018 Sep 26;8(1):14388. (PMID: 30258220)
      JAMA. 2004 Jul 28;292(4):490-5. (PMID: 15280347)
      J Am Geriatr Soc. 2014 Oct;62(10):1853-9. (PMID: 25283237)
      Int J Oral Sci. 2015 Jun 26;7(2):73-9. (PMID: 26023726)
      Matrix Biol. 2003 Mar;22(1):15-24. (PMID: 12714038)
      J Bone Miner Res. 2008 Jun;23(6):939-48. (PMID: 18282132)
      Arch Biochem Biophys. 2010 Nov 1;503(1):103-9. (PMID: 20655868)
      Br J Haematol. 2013 Dec;163(5):603-10. (PMID: 24111669)
      J Cell Biochem. 2012 Jan;113(1):220-8. (PMID: 21898543)
      J Cell Physiol. 2003 Jul;196(1):2-8. (PMID: 12767036)
      Endocr Rev. 2013 Oct;34(5):658-90. (PMID: 23612223)
      J Cell Physiol. 2004 Aug;200(2):169-76. (PMID: 15174088)
      Nat Rev Endocrinol. 2020 Feb;16(2):91-103. (PMID: 31792439)
      Sci Rep. 2020 Dec 3;10(1):21072. (PMID: 33273561)
      Bone. 2016 Apr;85:91-8. (PMID: 26851122)
      Cell Commun Signal. 2019 Feb 27;17(1):18. (PMID: 30813930)
      Cell Biochem Funct. 2013 Aug;31(6):451-9. (PMID: 23760768)
      Gene. 2012 Apr 25;498(1):1-4. (PMID: 22342254)
      Endocr Rev. 2011 Feb;32(1):31-63. (PMID: 20851921)
      Nature. 2008 Jun 5;453(7196):807-11. (PMID: 18432192)
      Sleep. 2013 Oct 01;36(10):1509-15. (PMID: 24082310)
      Biochem Biophys Res Commun. 2010 Mar 19;393(4):800-5. (PMID: 20171183)
      Nat Med. 2007 Jul;13(7):791-801. (PMID: 17618270)
      PLoS One. 2014 Jul 08;9(7):e102010. (PMID: 25003898)
      Inflamm Bowel Dis. 2014 Nov;20(11):1910-8. (PMID: 25192497)
      Exp Mol Med. 2004 Feb 29;36(1):1-12. (PMID: 15031665)
      Cytokine. 2017 Jan;89:155-159. (PMID: 26822707)
      Eur J Endocrinol. 2011 Apr;164(4):643-8. (PMID: 21289031)
      J Bone Miner Res. 2016 Oct;31(10):1877-1887. (PMID: 27082941)
      Bone. 2008 Apr;42(4):606-15. (PMID: 18280232)
      Nat Rev Mol Cell Biol. 2011 Dec 22;13(1):27-38. (PMID: 22189423)
      J Bone Miner Metab. 2015 Nov;33(6):615-24. (PMID: 25230819)
      Bone Res. 2019 May 13;7:14. (PMID: 31098335)
      J Physiol. 2011 Mar 15;589(Pt 6):1251-8. (PMID: 21078592)
      Adv Exp Med Biol. 2010;658:43-9. (PMID: 19950014)
      Sci Rep. 2016 Aug 02;6:30998. (PMID: 27481313)
      J Bone Miner Res. 2009 Aug;24(8):1347-53. (PMID: 19558314)
      BMC Musculoskelet Disord. 2017 May 31;18(1):236. (PMID: 28566092)
      Nat Rev Mol Cell Biol. 2020 May;21(5):268-283. (PMID: 32144406)
      J Cell Physiol. 2009 Jul;220(1):155-62. (PMID: 19259945)
      Bonekey Rep. 2014 Jan 08;3:481. (PMID: 24466412)
      Bone. 2016 Oct;91:130-8. (PMID: 27443510)
      Calcif Tissue Int. 2013 Feb;92(2):77-98. (PMID: 22782502)
      J Clin Invest. 2016 Oct 3;126(10):3699-3707. (PMID: 27571407)
      High Alt Med Biol. 2014 Jun;15(2):170-5. (PMID: 24666002)
      Science. 2001 Nov 9;294(5545):1337-40. (PMID: 11598268)
      J Biol Chem. 2013 Jul 5;288(27):19450-8. (PMID: 23671281)
      Osteoporos Int. 2008 Aug;19(8):1185-92. (PMID: 18224268)
      Nat Rev Endocrinol. 2019 Nov;15(11):651-665. (PMID: 31462768)
      Endocr Rev. 2000 Aug;21(4):393-411. (PMID: 10950158)
      Ann N Y Acad Sci. 2006 Dec;1092:385-96. (PMID: 17308163)
      Arch Biochem Biophys. 2008 May 15;473(2):139-46. (PMID: 18395508)
      J Bone Miner Metab. 2009;27(3):265-71. (PMID: 19333681)
      PLoS One. 2015 Mar 27;10(3):e0122821. (PMID: 25815722)
      Osteoporos Int. 2017 Jun;28(6):1835-1852. (PMID: 28101630)
      J Bone Miner Res. 2012 Mar;27(3):499-505. (PMID: 22354849)
      J Bone Miner Res. 1990 Sep;5(9):933-8. (PMID: 2281823)
      Biochem Biophys Res Commun. 2008 Jun 13;370(4):613-8. (PMID: 18402769)
      Cell Cycle. 2008 Jul 15;7(14):2090-6. (PMID: 18635960)
      Immunity. 2015 Jun 16;42(6):1062-74. (PMID: 26084024)
      Cell Biochem Funct. 2010 Jul;28(5):374-80. (PMID: 20556743)
      Osteoporos Int. 2016 Apr;27(4):1559-1568. (PMID: 26650379)
      Biomed Res Int. 2015;2015:421746. (PMID: 26247020)
      High Alt Med Biol. 2013 Jun;14(2):150-4. (PMID: 23795735)
      J Cell Sci. 2015 Dec 1;128(23):4353-65. (PMID: 26503158)
      Immunol Today. 1998 Feb;19(2):80-8. (PMID: 9509763)
      Int J Biochem Cell Biol. 2005 Mar;37(3):535-40. (PMID: 15618010)
      Cell Tissue Res. 2011 Feb;343(2):289-302. (PMID: 21120535)
      Physiol Rep. 2018 Mar;6(5):. (PMID: 29521037)
      PLoS One. 2010 May 27;5(5):e10853. (PMID: 20523730)
      Bone. 2019 Feb;119:36-41. (PMID: 29551752)
    • Contributed Indexing:
      Keywords: HIF; bone remodeling; hypoxia; osteoblast; osteoclast; oxygen
    • Publication Date:
      Date Created: 20220325 Date Completed: 20220408 Latest Revision: 20220408
    • Publication Date:
      20240104
    • Accession Number:
      PMC8953213
    • Accession Number:
      10.3390/ijms23063233
    • Accession Number:
      35328654